Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Aug 9;11(8):960.
doi: 10.3390/children11080960.

Pediatric Gaucher Disease Type 3 Presenting with Oculomotor Apraxia: A Case Report

Affiliations
Case Reports

Pediatric Gaucher Disease Type 3 Presenting with Oculomotor Apraxia: A Case Report

Margherita Di Costanzo et al. Children (Basel). .

Abstract

We report on a 4-year-old boy affected by Gaucher disease (GD) type 3, who presented with splenomegaly and a history of oculomotor apraxia. GD is a rare lysosomal storage disorder caused by glucocerebrosidase deficiency with multi-organ involvement. Besides common clinical features such as hepatosplenomegaly and skeletal involvement, less frequent neurological symptoms, such as oculomotor apraxia, are indicative of neuronopathic forms of the disease, namely GD type 3, to be confirmed both by enzyme activity and genetic testing. Overall, GD management requires a multidisciplinary approach involving metabolic pediatricians, neurologists, psychologists, and geneticists, and currently relies on early enzyme replacement therapy. Although enzyme replacement therapy has proved to be effective in improving systemic signs and symptoms, it is unable to alleviate neurological complications once these have occurred, as it does not pass across the blood-brain barrier. Neurological improvements may occur through indirect mechanisms. Thus, our case report aims to highlight the importance of considering GD in the differential diagnosis of pediatric patients presenting with splenomegaly associated with neurological manifestations, as early intervention may significantly modify the disease progression and prevent further irreversible complications.

Keywords: beta-glucocerebrosidase; enzyme replacement therapy; inherited metabolic diseases; lysosomal storage disorder; splenomegaly.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Brain and lower limbs MRI: (A,B) axial fluid-attenuated inversion recovery (FLAIR) and (D,E) T2-weighted Fast Spin-Echo (T2W-FSE) sequences revealed abnormal patchy hyperintense lesions (white arrows) in the dentate nuclei of the cerebellum at different levels. On coronal T1-weighted (C) and T2W-FSE (F) images, a subtle area of hypointensity signal was evident at the level of left tibia diaphysis (white arrow), finding that suggested bone marrow infiltration.

Similar articles

Cited by

References

    1. Weinreb N.J., Goker-Alpan O., Kishnani P.S., Longo N., Burrow T.A., Bernat J.A., Gupta P., Henderson N., Pedro H., Prada C.E., et al. The diagnosis and management of Gaucher disease in pediatric patients: Where do we go from here? Mol. Genet. Metab. 2022;136:4–21. doi: 10.1016/j.ymgme.2022.03.001. - DOI - PubMed
    1. Di Rocco M., Andria G., Deodato F., Giona F., Micalizzi C., Pession A. Early diagnosis of Gaucher disease in pediatric patients: Proposal for a diagnostic algorithm. Pediatr. Blood Cancer. 2014;61:1905–1909. doi: 10.1002/pbc.25165. - DOI - PubMed
    1. Stirnemann J., Belmatoug N., Camou F., Serratrice C., Froissart R., Caillaud C., Levade T., Astudillo L., Serratrice J., Brassier A., et al. A review of Gaucher disease pathophysiology, clinical presentation and treatments. Int. J. Mol. Sci. 2017;18:441. doi: 10.3390/ijms18020441. - DOI - PMC - PubMed
    1. Kurolap A., Del Toro M., Spiegel R., Gutstein A., Shafir G., Cohen I.J., Barrabés J.A., Feldman H.B. Gaucher disease type 3c: New patients with unique presentations and review of the literature. Mol. Genet. Metab. 2019;127:138–146. doi: 10.1016/j.ymgme.2019.05.011. - DOI - PubMed
    1. Bohlega S., Kambouris M., Shahid M., Al Homsi M., Al Sous W. Gaucher disease with oculomotor apraxia and cardiovascular calcification (Gaucher type IIIC) Neurology. 2000;54:261–263. doi: 10.1212/WNL.54.1.261. - DOI - PubMed

Publication types

LinkOut - more resources